Oura Ring's new AI promises clinical women's health guidance. But is this data goldmine a genuine leap forward or just deeper data extraction?
Intermittent fasting studies are facing a scientific reckoning. Discover the hidden conflict behind the sudden shift in the intermittent fasting debate.
The 'very dangerous' warnings about Google's AI Overviews delivering bad health advice reveal a deeper crisis in AI reliability and user trust.
The push for ethical governance of AI in cardiovascular disease management hides a deeper power shift. Who truly benefits from algorithmic cardiology?
Tactile Systems Technology (TCMD) EPS turnaround is a smokescreen. Dive into the hidden stagnation of this medical device darling.
Rethinking engagement in chronic disease care isn't about patient empowerment; it's about optimizing data streams for pharmaceutical giants. The real engagement is financial.
The FDA's Digital Health Center of Excellence isn't just about innovation; it’s about control. Unpacking the hidden power shift in modern healthcare technology.
Forget wellness breakthroughs. This 'mastermind' event exposes the real currency in **biohacking**—exclusivity, not data.
Investigating the true winners in pediatric healthcare technology adoption, beyond the glossy press releases from Rady Children’s and CHOC.
Forget supplements. A massive Cambridge study confirms your gut microbiome dictates health, exposing the next frontier in personalized medicine and corporate control.
AstraZeneca is banking on sustained **oncology demand** through 2026, but this isn't just about drugs; it's about market control and the future of **pharma technology** investment.
The FDA's Digital Health Center of Excellence signals a massive shift. Unpacking the true cost of centralized **digital health regulation** and **FDA oversight** in personalized **health tech**.